cerebrolysin: Clinical Trials

37 trials of cerebrolysin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 completed, 10 unknown, 3 terminated, 2 not yet recruiting. 12 Phase 4, 10 Phase 2, 6 Phase 3, 5 Not applicable, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 412Completed 5, Unknown 4, Recruiting 1, Terminated 1, Withdrawn 1
Phase 210Completed 4, Unknown 2, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Terminated 1
Phase 36Completed 4, Unknown 2
Not applicable5Unknown 2, Completed 1, Enrolling by invitation 1, Not yet recruiting 1
Phase 13Completed 2, Recruiting 1
Early Phase 11Unknown 1

Follow cerebrolysin: new trials by email Literature Review of cerebrolysin trials Research Report on cerebrolysin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combined Acupuncture-Based Therapy for Rehabilitation After Ischemic Stroke
Electro-Field Acupuncture, Electro-Acupuncture, Cerebrolysin - Ischemic Stroke, Hemiplegia
Not applicableNot yet recruitingNational Hospital of Acupuncture, Vietnam4402026-12-012026-09-29
Cerebrolysin After Reperfusion in Extended-window EndoVascular Thrombectomy
Cerebrolysin, Normal saline placebo - Acute Ischemic Stroke
Phase 2Not yet recruitingChang Gung Memorial Hospital1002026-09-012026-08-11
Cerebrolysin as an Add-On Therapy to Standard Treatment of Basilar Artery Occlusion
Cerebrolysin - Basilar Artery Occlusion, Posterior Circulation Brain Infarction
Early Phase 1UnknownUniversity Hospital Sestre Milosrdnice202024-07-012024-07-09
Cerebrolysin in Critically Ill Patients With Delirium
Cerebrolysin, Saline Solution - IV - Cognitive Impairment
Not applicableEnrolling by invitationMedical University of Lublin5002024-01-012024-12-31
CERebrolysin In CADASIL
Cerebrolysin, 0.9 % NaCl - Cadasil
Phase 2Active not recruitingEver Neuro Pharma GmbH302023-11-292025-02-25
A Prospective, Trial About Safety and Efficacy of Combined Treatment With Cerebrolysin in Acute Ischemic Hemispheric Stroke Patients Undergoing EndoVascular Treatment (EVT)
Cerebrolysin - Acute Ischemic Stroke
Not applicableUnknownShaare Zedek Medical Center302023-10-012023-10-06
Combined Cerebrolysin and Amantadine Sulfate Administration for Patients With Traumatic Brain Injury in the ICU
Cerebrolysin, amantadine sulfate - Traumatic Brain Injury
Phase 3CompletedAin Shams University1502023-09-012025-11-19
Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy
Prednisolone, Cerebrolysin - Bell Palsy
Phase 1 / Phase 2RecruitingOctober 6 University902023-08-242025-07-31
Efficacy and Safety of Cerebrolysin on Prolonged Disorders of Consciousness
Cerebrolysin, Control - Disorder of Consciousness, Hemorrhagic Stroke
Phase 4RecruitingKonkuk University Medical Center122023-06-012026-05-11
Cerebrolysin in Prevention of Postoperative Delirium in Cardiac Surgery
Cerebrolysin - Neurocognitive Disorders, Surgery-Complications
Not applicableUnknownMedical University of Lublin1002023-01-152024-01-10
CERebrolysine Effect on Blood-brain Barrier in acUte Ischemic Stroke
Cerebrolysin - Acute Ischemic Stroke
Phase 4UnknownPoznan University of Medical Sciences3502023-01-102023-10-13
Effect of Cerebrolysin on the Blood Brain Barrier in Patients With Diabetes and Ischemic Stroke
Cerebrolysin, Brain-MRI with contrast after 10-14 days of cerebrolysin - Ischemic Stroke, Acute, Diabetes Mellitus, Type 2
Phase 4UnknownHospital Universitario Dr. Jose E. Gonzalez602022-11-172024-02-22
Clinical Characteristics and Treatment of Anosmia and Ageusia Due to SARS-CoV2 Variants
Cerebrolysin, olfactory and gustatory trainings - Post-covid-19 Persistent Smell and Taste Disorders
Phase 4CompletedSherifa Ahmed Hamed1602021-08-302024-08-05
IMPULSE - StIMulation of Brain Plasticity to Improve Upper Limb Recovery After StrokE
Cerebrolysin, non-invasive brain stimulation, Placebo - Chronic Stroke, Subacute Stroke
Phase 2TerminatedEver Neuro Pharma GmbH42021-06-252022-07-28
Effects of Cerebrolysin on Level of Consciousness and Brain Metabolism in Disorder of Consciousness After Stroke: Single Center Randomized Controlled Study
Cerebrolysin, Placebo - Stroke
Phase 4UnknownYonsei University302021-06-012021-06-04
Early Administration of Cerebrolysin on the Outcome of Patients With Acute Stroke Undergoing EVT
Cerebrolysin - Stroke, Acute, Ischemic
Phase 2 / Phase 3UnknownPomeranian Medical University Szczecin1002021-04-272021-11-17
Efficacy of Cerebrolysin Treatment as an add-on Therapy to Mechanical Thrombectomy in Acute Ischemic Stroke.
Cerebrolysin - Stroke, Ischemic, Stroke, Acute
Phase 3UnknownMilitary Institute od Medicine National Research Institute502021-01-012022-08-24
Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia
Cerebrolysin - Covid19 Related Anosmia and Aguesia
Phase 3CompletedAssiut University2502020-08-012023-01-03
Evaluation of the Effect of Neuroprotective Drug on Treatment Result in Patients After Traumatic Brain Injury
Cerebrolysin - TBI (Traumatic Brain Injury)
CompletedPomeranian Medical University Szczecin562020-02-012023-04-11
Cerebrolysin REGistry Study in Stroke - a High-quality Observational Study of Comparative Effectiveness
Cerebrolysin - Acute Ischemic Stroke
CompletedEver Neuro Pharma GmbH18512018-04-242025-02-25

Showing 20 of 37. Sign in to see all of them.

Conditions studied

Ischemic Stroke (14)  ·  Stroke (8)  ·  Brain Injuries, Traumatic (3)  ·  Alzheimer Disease (2)  ·  COVID-19 (2)  ·  Cerebral Palsy (2)  ·  Critical Illness (2)  ·  Ageusia (1)  ·  Anosmia (1)  ·  Bell Palsy (1)  ·  Brain Infarction (1)  ·  Brain Injuries (1)  ·  CADASIL (1)  ·  Cognitive Dysfunction (1)  ·  Consciousness Disorders (1)

Sponsors

Ever Neuro Pharma GmbH (10)  ·  Ain Shams University (2)  ·  Clinical Institute of the Brain, Russia (2)  ·  Mansoura University Children Hospital (2)  ·  Medical University of Lublin (2)  ·  Pomeranian Medical University Szczecin (2)  ·  Samsung Medical Center (2)  ·  Assiut University (1)  ·  Chang Gung Memorial Hospital (1)  ·  Hospital Universitario Dr. Jose E. Gonzalez (1)  ·  Konkuk University Medical Center (1)  ·  Military Institute od Medicine National Research Institute (1)  ·  National Hospital of Acupuncture, Vietnam (1)  ·  October 6 University (1)  ·  Poznan University of Medical Sciences (1)

Countries

Egypt (8)  ·  Poland (6)  ·  Austria (5)  ·  South Korea (5)  ·  Russia (3)  ·  China (2)  ·  Czechia (2)  ·  Hong Kong (2)  ·  Mexico (2)  ·  Croatia (1)  ·  Israel (1)  ·  Slovakia (1)  ·  Slovenia (1)  ·  Spain (1)  ·  Vietnam (1)

Top investigators

Konrad Jarosz (2)  ·  Philipp Novak, PhD (2)  ·  Andreas Winkler, MD, MSc (1)  ·  Andrey Avgustovich Belkin, Prof.,MD,PhD (1)  ·  Deog Young Kim (1)  ·  Dieter Meier, MD (1)  ·  Herbert Moessler, PhD (1)  ·  Kennedy Lees, MD (1)  ·  Lixia Xue, M.D., Ph.D. (1)  ·  Manfred Windisch, PhD (1)  ·  Michael Brainin, Univ.-Prof. Dr. (1)  ·  Ragab D Elshabasy (1)

Results publications

PMID 37950370, PMID 20656516, PMID 21679156, PMID 22282884, PMID 22675077, PMID 23009193, PMID 26565631, PMID 26934986, PMID 27168844, PMID 28458021, PMID 29248999, PMID 29882581, PMID 31494820, PMID 31710397, PMID 32253535, PMID 32933176, PMID 32976665, PMID 33861548, PMID 34674598, PMID 35773197, PMID 35799508, PMID 35987197, PMID 36074398, PMID 36681145, PMID 37342446, PMID 37360873, PMID 37414511, PMID 37936249, PMID 38112945, PMID 38348284, PMID 38402273, PMID 38520278, PMID 38737662, PMID 40325343, PMID 40851188